The position involves defining the role of apolipoprotein (apo) E in neuropathology using human iPSC-derived. Protein changes(pathways) distinguishing apoE3 from apoE4-expressing neurons will be evaluated using CRISPR technology to knockdown or increase protein expression in iPSC-derived neurons.
Education/Skills Experience Required:
PhD or MD in cellular or molecular biology related field. Experience in one or more of the following areas are also desirable: iPSC cell culture, CRISPR genetic perturbation, neurobiology.
Please submit a CV including and cover letter describing background experience and future interests.
Internal Number: REQ-558
About Gladstone Institutes
The Gladstone Institutes is an independent, not-for-profit research institution affiliated with the University of California San Francisco (UCSF), transforming the health and well-being of all people through medical research, education, and outreach in the fields focused on heart disease, immunology and virology including HIV/AIDS, and neurological disease. Home to notable leaders in the field of medical science, including 2012 Nobel Prize in Physiology or Medicine recipient Shinya Yamanaka, M.D.,Ph.D. Gladstone is comprised of four institutes in addition to various Centers and programs focusing approximately 500 members of our team on its mission: Science Overcoming Disease. Located in an award-winning building adjacent to UCSF's Mission Bay Campus, Gladstone offers a competitive salary and benefits program within a robust environment for those seeking to maximize their potential. Please consider Gladstone and make a difference in human health.
